NCT04005482

Blood Pressure During Rate Control in Patients With Tachycardic Atrial Fibrillation at the Emergency Department

• Status: Unknown
• Phase: —
• Study type: Observational
• Enrollment: 140 (estimated)
• Sponsor: Medical University of Vienna · Academic / Other
• Sex: All
• Age: 18 Years – 120 Years
• Healthy volunteers: Not accepted

Summary

The aim of this study is to analyse blood pressure during rate control therapy in patients with tachycardic atrial fibrillation in a real-world emergency cohort.

Detailed description

Atrial fibrillation (AF) is the primary clinical problem in 3.3% to 10.0 % emergency department (ED) admissions. Rate control is an integral part of the management of symptomatic tachycardic AF patients. According to the recent guidelines beta-blockers, digoxin, the calcium channel blockers diltiazem and verapamil, amiodarone or combination therapy should be considered for rate control. Haemodynamic side-effects in particular hypotension may occur. Heart rate and blood pressure behavior in an ED population during rate control therapy in patients with tachycardic atrial fibrillation will be analysed.

Conditions

• Atrial Fibrillation

Interventions

Type	Name	Description
OTHER	Rate control	Rate control according to the Atrial fibrillation - ESC Guidelines 2016

Timeline

• Start date: 2019-09-20
• Primary completion: 2021-07-20
• Completion: 2021-07-20
• First posted: 2019-07-02
• Last updated: 2019-09-17